Employees: 11 (2023.0)Legal category: 5202Size: PMECreation date: 1993-08-23 (32 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: VOLGELSHEIM ([ND]), None
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SNC PHARMACIE BOLOGNA DOSSMANN is a French company
founded 32 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in VOLGELSHEIM ([ND]),
this company of category PME
shows in 2016 a revenue of 2.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SNC PHARMACIE BOLOGNA DOSSMANN (SIREN 392596391)
Indicator
2024
2023
2016
Revenue
N/C
N/C
2 200 181 €
Net income
284 295 €
87 624 €
198 167 €
EBITDA
N/C
N/C
196 147 €
Net margin
N/C
N/C
9.0%
Revenue and income statement
In 2024, SNC PHARMACIE BOLOGNA DOSSMANN generates positive net income of 284 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 198 k€ -> 284 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
284 295 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 4%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 33%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
3.958%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
33.273%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2023
2024
Debt ratio
259.039
4.529
3.958
Financial autonomy
23.139
11.397
33.273
Repayment capacity
2.781
None
None
Cash flow / Revenue
8.854%
None%
None%
Sector positioning
Debt ratio
3.962024
2016
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Excellent-42 pts over 3 years
In 2024, the debt ratio of SNC PHARMACIE BOLOGNA DOS... (3.96) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.
Financial autonomy
33.27%2024
2016
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of SNC PHARMACIE BOLOGNA DOS... (33.3%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
2.78 years2016
2016
Q1: 2.17 years
Med: 6.32 years
Q3: 11.13 years
Good
In 2016, the repayment capacity of SNC PHARMACIE BOLOGNA DOS... (2.78) ranks below the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. This controlled position reflects prudent management.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 101.74. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2023
2024
Liquidity ratio
334.109
63.079
101.741
Interest coverage
0.0
None
None
Sector positioning
Liquidity ratio
101.742024
2016
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch-54 pts over 3 years
In 2024, the liquidity ratio of SNC PHARMACIE BOLOGNA DOS... (101.74) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
0.0x2016
2016
Q1: 4.69x
Med: 10.82x
Q3: 19.31x
Average
In 2016, the interest coverage of SNC PHARMACIE BOLOGNA DOS... (0.0x) ranks below the median of the sector. This ratio indicates how many times operating income covers interest expenses. An improvement would strengthen the competitive position.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution SNC PHARMACIE BOLOGNA DOSSMANN
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2023
2024
Operating WCR
92 760 €
0 €
0 €
Inventory turnover (days)
25
0
0
Customer payment term (days)
3
0
0
Supplier payment term (days)
14
0
0
Positioning of SNC PHARMACIE BOLOGNA DOSSMANN in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SNC PHARMACIE BOLOGNA DOSSMANN is estimated at
3 968 968 €
(range 2 763 926€ - 5 937 803€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
2763k€3968k€5937k€
3 968 968 €Range: 2 763 926€ - 5 937 803€
NAF 5 année 2024
Valuation method used
Net Income Multiple
284 295 €
×
14.0x
=3 968 968 €
Range: 2 763 927€ - 5 937 804€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SNC PHARMACIE BOLOGNA DOSSMANN with other companies in the same sector:
Frequently asked questions about SNC PHARMACIE BOLOGNA DOSSMANN
What is the revenue of SNC PHARMACIE BOLOGNA DOSSMANN ?
The revenue of SNC PHARMACIE BOLOGNA DOSSMANN in 2016 is 2.2 M€.
Is SNC PHARMACIE BOLOGNA DOSSMANN profitable?
Yes, SNC PHARMACIE BOLOGNA DOSSMANN generated a net profit of 284 k€ in 2024.
Where is the headquarters of SNC PHARMACIE BOLOGNA DOSSMANN ?
The headquarters of SNC PHARMACIE BOLOGNA DOSSMANN is located in VOLGELSHEIM ([ND]).
Where to find the tax return of SNC PHARMACIE BOLOGNA DOSSMANN ?
The tax return of SNC PHARMACIE BOLOGNA DOSSMANN is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SNC PHARMACIE BOLOGNA DOSSMANN operate?
SNC PHARMACIE BOLOGNA DOSSMANN operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart